These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 24125828)

  • 1. β-Catenin and cyclin D1 expression in Gli1-independent basal cell carcinomas.
    Aguayo RS; Rafel M; Santacana M; Fernández RM; Sanmartín V; Casanova JM; Gari E
    Eur J Dermatol; 2013; 23(5):734-6. PubMed ID: 24125828
    [No Abstract]   [Full Text] [Related]  

  • 2. Gli1 protein is expressed in basal cell carcinomas, outer root sheath keratinocytes and a subpopulation of mesenchymal cells in normal human skin.
    Ghali L; Wong ST; Green J; Tidman N; Quinn AG
    J Invest Dermatol; 1999 Oct; 113(4):595-9. PubMed ID: 10504446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
    Saldanha G; Ghura V; Potter L; Fletcher A
    Br J Dermatol; 2004 Jul; 151(1):157-64. PubMed ID: 15270885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and significance of adenomatous polyposis coli, beta-catenin, E-cadherin and cyclin D1 in esophageal squamous cell carcinoma assessed by tissue microarray.
    Peng H; Zhong XY; Liu KP; Li SM
    Ai Zheng; 2009 Jan; 28(1):38-41. PubMed ID: 19448414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma.
    Kim DJ; Kim J; Spaunhurst K; Montoya J; Khodosh R; Chandra K; Fu T; Gilliam A; Molgo M; Beachy PA; Tang JY
    J Clin Oncol; 2014 Mar; 32(8):745-51. PubMed ID: 24493717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expressions of Ki-67, cyclin D1, beta-catenin, cyclooxygenase-2, and epidermal growth factor receptor in human colorectal adenoma: a validation study of tissue microarrays.
    Su Y; Shrubsole MJ; Ness RM; Cai Q; Kataoka N; Washington K; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1719-26. PubMed ID: 16985035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microcystic Stromal Tumor: A Distinctive Ovarian Sex Cord-Stromal Neoplasm Characterized by FOXL2, SF-1, WT-1, Cyclin D1, and β-catenin Nuclear Expression and CTNNB1 Mutations.
    Irving JA; Lee CH; Yip S; Oliva E; McCluggage WG; Young RH
    Am J Surg Pathol; 2015 Oct; 39(10):1420-6. PubMed ID: 26200099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
    Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N
    Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gli1, downregulated in colorectal cancers, inhibits proliferation of colon cancer cells involving Wnt signalling activation.
    Akiyoshi T; Nakamura M; Koga K; Nakashima H; Yao T; Tsuneyoshi M; Tanaka M; Katano M
    Gut; 2006 Jul; 55(7):991-9. PubMed ID: 16299030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1 is a downstream target of Gli1 in basal cell carcinomas.
    Teh MT; Wong ST; Neill GW; Ghali LR; Philpott MP; Quinn AG
    Cancer Res; 2002 Aug; 62(16):4773-80. PubMed ID: 12183437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of telomerase activity and correlation with mitotic and apoptotic indices, Ki-67 and expression of cyclins D1 and A in cutaneous melanoma.
    Miracco C; Pacenti L; Santopietro R; Biagioli M; Fimiani M; Perotti R; Rubegni P; Pirtoli L; Luzi P
    Int J Cancer; 2000 Nov; 88(3):411-6. PubMed ID: 11054670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
    Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
    Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear localization of beta-catenin is correlated with the expression of cyclin D1 in endometrial carcinomas.
    Shih HC; Shiozawa T; Miyamoto T; Uchikawa J; Feng Y; Kashima H; Nikaido T; Konishi I
    Anticancer Res; 2003; 23(5A):3749-54. PubMed ID: 14666673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma.
    Ueta T; Ikeguchi M; Hirooka Y; Kaibara N; Terada T
    Oncol Rep; 2002; 9(6):1197-203. PubMed ID: 12375019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of proteins: D1 cyclin and Ki-67 in papillary thyroid carcinomas.
    Timler D; Tazbir J; Matejkowska M; Gosek A; Czyz W; Brzeziński J
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():201-2. PubMed ID: 11820608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of beta-catenin, a key mediator of the WNT signaling pathway, in basal cell carcinoma.
    Boonchai W; Walsh M; Cummings M; Chenevix-Trench G
    Arch Dermatol; 2000 Jul; 136(7):937-8. PubMed ID: 10891006
    [No Abstract]   [Full Text] [Related]  

  • 17. RUNX3 protein is overexpressed in human basal cell carcinomas.
    Salto-Tellez M; Peh BK; Ito K; Tan SH; Chong PY; Han HC; Tada K; Ong WY; Soong R; Voon DC; Ito Y
    Oncogene; 2006 Dec; 25(58):7646-9. PubMed ID: 16767156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression.
    Lantsov D; Meirmanov S; Nakashima M; Kondo H; Saenko V; Naruke Y; Namba H; Ito M; Abrosimov A; Lushnikov E; Sekine I; Yamashita Sh
    Histopathology; 2005 Sep; 47(3):248-56. PubMed ID: 16115225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma.
    Schmitt-Graeff A; Ertelt-Heitzmann V; Allgaier HP; Olschewski M; Nitschke R; Haxelmans S; Koelble K; Behrens J; Blum HE
    Liver Int; 2005 Aug; 25(4):839-47. PubMed ID: 15998435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.